Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis

J Hepatol. 2020 Oct;73(4):967-970. doi: 10.1016/j.jhep.2020.06.021. Epub 2020 Jun 22.

¹ Division of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: Montserrat.Fraga@chuv.ch.
² Division of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
³ Division of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁴ Adult Intensive Care Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁵ Division of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁶ Department of Genetic Medicine and Development, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
⁷ Division of Angiology and Hemostasis, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
⁸ Division and Central Laboratory of Hematology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁹ Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

No abstract available

Publication types